🇺🇸 FDA
Patent

US 7119200

Pyrazolopyrimidines as cyclin dependent kinase inhibitors

granted A61KA61K31/495A61P

Quick answer

US patent 7119200 (Pyrazolopyrimidines as cyclin dependent kinase inhibitors) held by Pharmacopeia Drug Discovery, Inc. expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pharmacopeia Drug Discovery, Inc.
Grant date
Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/495, A61P, A61P19/02, A61P25/28